Thermo Fisher Scientific Inc. is pleased to
announce an efficient, comprehensive
HPLC
QC method using an Acclaim Phenyl-1 Column for the separation of all six main
active components of Caulis Lonicerae, an important traditional Chinese
medicine. To regulate this natural treatment used for acute fever, headache,
respiratory infection, and epidemic diseases, the
Pharmacopoeia
of the People's Republic of China (PPRC) requires two different methods,
which combined only identify two main target components.
Application Note 299:
HPLC Analysis of Six Active
Components of Caulis Lonicerae Using a Phenyl-1 Column details
the baseline resolution of loganin, sweroside, chlorogenic acid, caffeic acid,
rutin, and galuteolin of the dried rattan of Lonicera japonica (Caprifoliaceae
or honeysuckle family). Other HPLC methods that can identify the active
components require long separation times and have insufficient peak resolution.
This application and many others can be found at
www.thermoscientific.com/dionex
under the
Documents
tab.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world
leader in serving science. Our mission is to enable our customers to make the
world healthier, cleaner and safer. With revenues of $12 billion, we have
approximately 39,000 employees and serve customers within pharmaceutical and
biotech companies, hospitals and clinical diagnostic labs, universities,
research institutions and government agencies, as well as in environmental and
process control industries. We create value for our key stakeholders through
three premier brands, Thermo Scientific, Fisher Scientific and Unity
TM Lab
Services, which offer a unique combination of innovative technologies,
convenient purchasing options and a single solution for laboratory operations
management. Our products and services help our customers solve complex
analytical challenges, improve patient diagnostics and increase laboratory
productivity.
All trademarks are the property of Thermo Fisher
Scientific Inc. and its subsidiaries.
